ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2025
Assessing the association between mortality and clinical follow-up visits in multiple sclerosis.
Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe relationship between attendance at specialized multiple sclerosis (MS) clinics and mortality has not been fully evaluated.
objectiveWe investigated the association between visits to specialized care in Danish MS clinics and mortality.
methodsWe collected data from Danish national registers to assess survival among people with MS according to the number of visits in MS clinics. We employed the Kaplan-Meier method and extended Cox regression modelling.
resultsIn total, 9929 patients with MS were included in the study, contributing 105 115 person-years at risk. A total of 316 patients with MS died during a median follow-up of 10.3 years. Cumulative visits were not statistically associated with mortality (hazard ratio (HR), 95% confidence interval (CI) = 1.00, 0.99-1.02). Female sex (0.68, 0.53-0.87), being divorced (0.56, 0.37-0.86), being married or in a partnership (0.60, 0.45-0.79) and higher education (0.64, 0.45-0.91) were independently associated with reduced mortality. Expanded Disability Status Scale (EDSS) ⩾ 3 (2.38, 1.60-3.54), ischaemic cerebrovascular disease (1.97, 1.42-2.75) and pneumonia (7.03, 5.48-9.02) were associated with an increased mortality.
conclusionWe found no association between visits to specialized care and mortality. Our findings suggest that improving survival in patients with MS may require a focus on quality and content of care and proactive management of comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.